
⸺ Synova Research
Nicotinamide adenine dinucleotide — a central coenzyme studied for mitochondrial function, cellular energy metabolism and longevity research.
Secure checkout via UK open banking. Free shipping on orders over £100.
Independently tested
COA on request
Next-day UK dispatch
Order before midnight
Research use only
Not for human consumption
⸺ Important
⸺ Overview
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. Researchers study it for its role in mitochondrial respiration, redox balance, sirtuin and PARP enzyme activity, and broader cellular ageing and metabolism models.
⸺ Mechanism of Action
NAD+ acts as an electron carrier in oxidative phosphorylation and as a substrate for sirtuins, PARPs and CD38. Restoring NAD+ levels in animal models has been associated with improved mitochondrial function, DNA-repair capacity and metabolic resilience.
⸺ Research
Animal studies show improved mitochondrial output and energy markers following NAD+ supplementation in aged tissues.
Research describes increased sirtuin-mediated deacetylation, linked to metabolic and stress-response pathways.
Preclinical work has examined NAD+ in ageing models, with reported improvements in muscle, neurological and metabolic markers.
Summarised from preclinical literature for informational purposes only. Not medical or veterinary advice. Synova Research products are sold strictly for in-vitro and laboratory research.
⸺ Details

Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied in animal models for appetite control, energy expenditure and glucose balance.

Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.

Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.